BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 23948302)

  • 1. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
    Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
    J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice.
    Zhang M; Wang Y; Zhu G; Sun C; Wang J
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):189-204. PubMed ID: 32474674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.
    Chou WY; Lu CN; Lee TH; Wu CL; Hung KS; Concejero AM; Jawan B; Wang CH
    Acta Pharmacol Sin; 2006 Apr; 27(4):469-76. PubMed ID: 16539848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.
    Yang YY; Huang YT; Lee TY; Chan CC; Yeh YC; Lee KC; Lin HC
    Liver Transpl; 2012 Nov; 18(11):1371-83. PubMed ID: 22847887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice.
    Lee TH; Jawan B; Chou WY; Lu CN; Wu CL; Kuo HM; Concejero AM; Wang CH
    J Gene Med; 2006 Jun; 8(6):764-72. PubMed ID: 16508911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
    Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
    J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
    Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
    Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
    FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.
    Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H
    Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
    Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
    Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
    Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
    J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway.
    Yang N; Dang S; Shi J; Wu F; Li M; Zhang X; Li Y; Jia X; Zhai S
    Biochem Biophys Res Commun; 2017 Apr; 486(1):22-28. PubMed ID: 28193525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
    Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
    J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.
    Chen Y; Huang Y; Reiberger T; Duyverman AM; Huang P; Samuel R; Hiddingh L; Roberge S; Koppel C; Lauwers GY; Zhu AX; Jain RK; Duda DG
    Hepatology; 2014 Apr; 59(4):1435-47. PubMed ID: 24242874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
    Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
    J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
    Ma J; Qiu Y; Wang M; Zhang M; Zhao X; Jiang H
    Dig Dis Sci; 2019 Sep; 64(9):2570-2580. PubMed ID: 30874989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.